1. Home
  2. RNXT vs PRT Comparison

RNXT vs PRT Comparison

Compare RNXT & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • PRT
  • Stock Information
  • Founded
  • RNXT 2012
  • PRT 2017
  • Country
  • RNXT United States
  • PRT United States
  • Employees
  • RNXT N/A
  • PRT N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • PRT Oil & Gas Production
  • Sector
  • RNXT Health Care
  • PRT Energy
  • Exchange
  • RNXT Nasdaq
  • PRT Nasdaq
  • Market Cap
  • RNXT 44.6M
  • PRT 47.6M
  • IPO Year
  • RNXT 2021
  • PRT N/A
  • Fundamental
  • Price
  • RNXT $1.36
  • PRT $4.08
  • Analyst Decision
  • RNXT Strong Buy
  • PRT
  • Analyst Count
  • RNXT 2
  • PRT 0
  • Target Price
  • RNXT $7.25
  • PRT N/A
  • AVG Volume (30 Days)
  • RNXT 190.7K
  • PRT 29.4K
  • Earning Date
  • RNXT 08-12-2025
  • PRT 08-08-2025
  • Dividend Yield
  • RNXT N/A
  • PRT 10.63%
  • EPS Growth
  • RNXT N/A
  • PRT 6.25
  • EPS
  • RNXT N/A
  • PRT 0.45
  • Revenue
  • RNXT $240,000.00
  • PRT $6,430,197.00
  • Revenue This Year
  • RNXT $3,186.05
  • PRT N/A
  • Revenue Next Year
  • RNXT $291.93
  • PRT N/A
  • P/E Ratio
  • RNXT N/A
  • PRT $9.06
  • Revenue Growth
  • RNXT N/A
  • PRT 5.12
  • 52 Week Low
  • RNXT $0.75
  • PRT $3.26
  • 52 Week High
  • RNXT $1.69
  • PRT $4.63
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 58.97
  • PRT 56.76
  • Support Level
  • RNXT $1.26
  • PRT $3.90
  • Resistance Level
  • RNXT $1.40
  • PRT $4.15
  • Average True Range (ATR)
  • RNXT 0.05
  • PRT 0.11
  • MACD
  • RNXT -0.01
  • PRT 0.01
  • Stochastic Oscillator
  • RNXT 48.70
  • PRT 62.07

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About PRT PermRock Royalty Trust Trust Units

PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.

Share on Social Networks: